About Auronext Pharma
Auronext Pharma is a company based in Hyderabad (India) founded in 2009. It operates as a B2B. The company has 13,881 employees. Auronext Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 13,881
- SectorsHealthcare
- Website auronext.com
- Employee Count13,881
Associated legal entities of Auronext Pharma
Auronext Pharma is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Auronext Pharma Private Limited CIN U74999TG2009PTC109591 | Amalgamated | 02 Jul 2009 | Hyderabad, Telangana | ₹0.8 Cr | 293 | 7 | View details |
| Aurobindo Pharma Ltd Listed CIN L24239TG1986PLC015190 | Active | 26 Dec 1986 | Hyderabad, Telangana | ₹34,145 Cr | 15,925 | 11 | View details |
Board of directors of Auronext Pharma
The boards of the 2 registered companies of Auronext Pharma currently have 12 directors; the longest-serving is Venkata Ramprasad Reddy Penaka, appointed in 1992. 37 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkata Ramprasad Reddy Penaka DIN 01284132 | Director | 30 Dec 1992 | 33 yrs 9 mo | Aurobindo Pharma Ltd |
| Nityananda Reddy Kambam DIN 01284195 | Managing Director | 30 Dec 1992 | 33 yrs 9 mo | Aurobindo Pharma Ltd |
| Sarath Chandra Reddy Penaka DIN 01628013 | Director | 27 Sep 2007 | 19 yrs | Aurobindo Pharma Ltd, Auronext Pharma Private Limited |
| Madan Mohan Reddy Mettu DIN 01284266 | Whole-time director | 01 Jan 2013 | 13 yrs 9 mo | Aurobindo Pharma Ltd, Auronext Pharma Private Limited |
| Venkata Radhakrishna Racharla DIN 00763862 | Company Secretary | 15 Apr 2019 | 7 yrs 5 mo | Auronext Pharma Private Limited |
| Sapna DIN 08434059 | Director | 23 May 2019 | 7 yrs 4 mo | Auronext Pharma Private Limited |
| Girish Paman Vanvari DIN 07376482 | Director | 05 Nov 2020 | 5 yrs 11 mo | Aurobindo Pharma Ltd |
| Jacob Joseph DIN 08432306 | Whole-time director | 01 Jul 2021 | 5 yrs 3 mo | Auronext Pharma Private Limited |
| Santanu Mukherjee DIN 07716452 | Director | 09 Feb 2023 | 3 yrs 8 mo | Aurobindo Pharma Ltd |
| Satakarni Makkapati DIN 09377266 | Director | 09 Nov 2023 | 2 yrs 11 mo | Aurobindo Pharma Ltd |
| Mangalam Ramasubramanian Kumar DIN 03628755 | Director | 01 Apr 2024 | 2 yrs 6 mo | Aurobindo Pharma Ltd |
| Punita Kumar Sinha DIN 05229262 | Director | 09 Feb 2026 | 7 mo | Aurobindo Pharma Ltd |
Financials of Auronext Pharma
Figures of Aurobindo Pharma Ltd, the primary company behind Auronext Pharma, for FY 2026. Revenue was ₹34,145 Cr (+6% year on year). Net profit was ₹3,503 Cr (10% margin). EBITDA was ₹53,281 Cr (156% margin). Revenue has grown at a compounded annual rate of +11% over three years and +6% over five years.
- ₹34,145 CrRevenue · FY 2026 · +6% YoY
- ₹3,503 CrNet profit · 10% margin
- ₹53,281 CrEBITDA · 156% margin
- ₹57.54 CrPaid-up capital
- 15,925Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aurobindo Pharma Ltd are on its company page.
Detailed financial statements for Auronext Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Auronext Pharma
Auronext Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Auronext Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Auronext Pharma
10 companies that operate in the same segment as Auronext Pharma (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Auronext Pharma
Auronext Pharma was founded in 2009.
Auronext Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Auronext Pharma has 13,881 employees.
Auronext Pharma, established in 2009, excels in providing healthcare solutions, producing pharmaceutical products, api manufacturing, and outsourced services. Offers comprehensive outsourced API production services for the pharmaceutical industry. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Auronext Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Auronext Pharma is associated with 2 legal entities: Aurobindo Pharma Ltd, Auronext Pharma Private Limited.
The legal entities of Auronext Pharma currently have 15 directors, including Girish Paman Vanvari, Venkata Ramprasad Reddy Penaka, Madan Mohan Reddy Mettu and others.